GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human ppargamma ligand binding domain in complex with mitoglitazone

Analyse Crystal structure of human ppargamma ligand binding domain in complex with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6O67
Type
protein
Length
511 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Peroxisome proliferator-activated receptor gamma
UniProt
P37231
Ligands
LO7, KNA
Pockets
8 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 66% helix, 5% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APeroxisome proliferator-activated receptor gammaprotein25765% helix, 5% strandP37231
BPeroxisome proliferator-activated receptor gammaprotein25467% helix, 5% strandP37231

Ligands and binding sites

  • LO7 · Mitoglitazone · ligand · chains A
  • KNA · nonanoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
18240.810.8378empty
25140.780.8552LO7, KNA
31340.620.8621empty
41300.600.8524empty
52320.560.7829empty

Interfaces

1 interface between chains.

  • A–B · 1059 Ų buried · 19 hydrogen bonds · protein-protein

Compared structures

  • 6O67 · Crystal Structure of Human PPARgamma Ligand Binding Domain in Complex with Mitoglitazone · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.